What Causes Elevated High-Sensitivity C-Reactive Protein (hs-CRP)?

High-sensitivity C-reactive protein (hs-CRP) is a form of C-reactive protein (CRP) found in plasma, also known as high-sensitivity CRP. Its clinical utility primarily lies in risk assessment for cardiovascular diseases, neonatal bacterial infections, and kidney transplantation. So, what causes elevated hs-CRP levels? Let’s explore this further.

Causes of Elevated High-Sensitivity C-Reactive Protein

High-sensitivity C-reactive protein is a plasma acute-phase reactant synthesized in the liver. It serves as a nonspecific biomarker of systemic inflammatory response during the acute phase and is one of the strongest predictive indicators of cardiovascular events.

Infection is the most common cause—particularly acute bacterial inflammation, as well as active phases of chronic inflammatory conditions such as tuberculosis, rheumatic fever, and connective tissue disorders. Thus, hs-CRP can serve as an indicator of disease activity.

Elevated hs-CRP levels are also observed in myocardial infarction, stroke, and severe peripheral arterial disease. Clinically, it is primarily used for dynamic monitoring of angina pectoris in coronary artery disease patients.

Pathological Research on High-Sensitivity C-Reactive Protein

Studies have shown that elderly patients with acute ischemic stroke who exhibit elevated CRP levels tend to have poorer prognoses. Moreover, hs-CRP concentration correlates with infarct size and severity of neurological deficits, making it one of the indicators reflecting disease severity in ischemic stroke patients. CRP also participates in thrombus formation and the pathogenesis of atherosclerosis, thereby representing an independent risk factor for stroke.

Inflammatory responses within atherosclerotic plaques are key contributors to plaque rupture and instability. During atherosclerotic plaque development, CRP, complement complexes, and foam cells accumulate within the arterial wall. CRP binds to lipoproteins, activates the complement system, triggers release of abundant pro-inflammatory mediators and reactive oxygen species, leading to endothelial injury, vasospasm, and detachment of unstable plaques—thereby exacerbating luminal narrowing caused by atherosclerosis and increasing the risk of acute cerebral infarction (ACI).

Growing evidence indicates that even low-grade elevations in CRP are closely associated with other cardiovascular risk factors—including hypertension and hyperlipidemia. Furthermore, elevated CRP levels increase the incidence of cardiac events and stroke among hypertensive patients. Therefore, CRP functions as a pro-inflammatory cytokine intimately involved in the initiation, progression, and evolution of atherosclerosis. Epidemiological studies demonstrate that individuals with elevated hs-CRP levels face twice the risk of acute stroke and three times the risk of myocardial infarction compared to healthy controls. The 2003 European Society of Hypertension/European Society of Cardiology (ESH/ESC) Guidelines for the Management of Arterial Hypertension formally recommended measuring hs-CRP levels in hypertensive patients.

The above provides an overview of the potential causes underlying elevated high-sensitivity C-reactive protein. We hope this information proves helpful to you.